Abstract
BackgroundAnti-TNF therapy has been shown to be clinically efficacious in patients with ankylosing spondylitis (AS) but there is no evidence that it inhibits new bone formation. Biomarkers of increased bone...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
